Table 2.

Prognostic performance measures.

Test	Sensitivity (95% CI)	p-Value	Specificity (95% CI)	p-Value	LR+ (95% CI)	p-Value	LR− (95% CI)	p-Value
MR-proADMt0 ≥ 2.78 nmol/L	81.3% (62.1–100)	-	64.6% (55.6–73.5)	-	2.3 (1.6–3.2)	-	0.3 (0.1–0.8)	-
MR-proADMt72 ≥ 2.7 nmol/L	68.8% (46.0–91.5)	0.5	80.0% (72.5–87.5)	<0.001	3.4 (2.1–5.7)	0.05	0.4 (0.2–0.8)	0.4
MR-proADM%change ≥ −15.2%	75.0% (53.8–96.2)	1.0	70.0% (61.4–78.6)	0.5	2.5 (1.7–3.7)	0.8	0.4 (0.2–0.8)	0.8

LR: likelihood ratio.